Clinical trialNCT07141394Not, yet, recruitingInterventional

Coordinated Access for Addiction Recovery and Equity in VA Supportive Housing

SponsorVA Office of Research and DevelopmentEnrollment7,908HomelessnessSubstance Use Disorder (SUD)

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The Department of Housing and Urban Development-VA Supportive Housing (HUD-VASH) Program provides subsidized permanent housing with case management to homeless-experienced Veterans (HEVs). Up to 40% of Veterans exit HUD-VASH within two years of attaining housing; substance use disorders (SUDs) are one of the largest causes of returns to homelessness for HEVs. CARE-VASH QUERI proposes to implement and evaluate two evidence-based SUD services - Medications for addiction treatment (MAT) and cognitive behavioral therapy for SUDs (CBT-SUD) - among Veterans in HUD-VASH.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Emily Treichler, PhD
VA San Diego Healthcare System, San Diego, CA
Principal Investigator
clinicaltrials.gov ↗
Erin P Finley, PhD MPH
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Principal Investigator
clinicaltrials.gov ↗
Evelyn T Chang, MD MSHS
VA Greater Los Angeles Healthcare System, Sepulveda, CA
Principal Investigator
clinicaltrials.gov ↗
Sonya Emi Gabrielian, MD MPH
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Va Greater Los Angeles Healthcare System, West Los Angeles, Ca
West Los Angeles, California, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Medication for Addiction Treatment

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Oct 2026
Primary completion: 30 Sept 2030
Completion: 30 Sept 2030
Last update posted: 10 Oct 2025
Registered enrollment: 7,908
Registry id: NCT07141394

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.